Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles

Atherosclerosis

Volumn 139, Issue 2, 1998, Pages 363-367

  Inoue, Teruo ^a   Saniabadi, Abby R ^b   Matsunaga, Riichiro ^a   Hoshi, Kazuhiro ^a   Yaguchi, Isao ^a   Morooka, Shigenori ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

Acetylcholine; Acetylcholine provocation test; Cholesterol; Coronary artery disease; Endothelium; Remnant lipoproteins; Triglyceride

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED RELAXING FACTOR;

ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; LIPOPROTEIN METABOLISM; MEDIATOR RELEASE; PRIORITY JOURNAL; PROVOCATION TEST; SMOOTH MUSCLE CONTRACTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ACETYLCHOLINE; AGED; APOLIPOPROTEINS; ARTERIES; CHOLESTEROL; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; LIPOPROTEINS; MALE; MIDDLE AGED; TRIGLYCERIDES; VASODILATION;

EID: 0031858750     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00098-7     Document Type: Article

References (22)

1. Moncada S., Herman A.G., Higgs E.A.et al. Differential formation of prostacyclin (PGX or PGI2) by layers of arterial wall: an explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res. 11:1977;323-344.
2. Ignarro L.J., Byrns R.E., Buga G.M.et al. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium dependent and nitric oxide elicited vascular smooth muscle cell relaxation. J Pharmacol Exp Ther. 244:1988;181-189.
3. Yanagisawa M., Kurihara H., Kimura H.et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
4. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
5. Reddy K.G., Nair R., Heehan H.M.et al. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis. J Am Coll Cardiol. 23:1994;833-843.
6. Greager M.A., Cooke J.P., Mendelhson M.E. Impaired vasodilation of forearm resistance vessels in hypercholesterolaemic humans. J Clin Invest. 86:1990;228-234.
7. Weisgraber K.H. Apolipoprotein E: structure-function relationships. Adv Protein Chem. 45:1995;249-302.
8. Mahley R.W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
9. Nakajima K., Saito T., Tamura A.et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta. 223:1993;53-71.
10. Campos E., Nakajima K., Tanaka A.et al. Properties of an apo E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res. 33:1992;369-380.
11. Nakajima K., Saito T., Tamura A.et al. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. J Atheroscler Thromb. 1:1994;30-36.
12. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
13. Johnstone M.T., Greager S.J., Scales K.M.et al. Impaired endothelium-dependent vasodilation in patients with insulin dependent diabetes millitus. Circulation. 88:1993;2510-2516.
14. Grylewski R.J., Palmer R.M.J., Moncada S. Superoxide is involved in the breakdown of endothelium derived vascular relaxing factor. Nature. 320:1986;454-456.
15. Lipton S.A., Choi Y.B., Pan Z.H.et al. A redox mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
16. Casino P.R., Kilcoyne C.M., Quyyumi A.A.et al. Role of nitric oxide in endothelium dependent vasodilation in hypercholesterolaemic patients. Circulation. 88:1993;2541-2547.
17. Casino P.R., Kilcoyne C.M., Cannon R.O.et al. Impaired endothelium dependent vascular relaxation in patients with hypercholesterolaemia extends beyond the muscarinic receptor. Am J Cardiol. 75:1995;40-44.
18. Garcia C.E., Kilcoyne C.M., Cardillo C.et al. Evidence that endothelial dysfunction in hypercholesterolaemia is not due to increased extracellular nitric oxide breakdown by superoxide anion. Am J Cardiol. 76:1995;1157-1161.
19. Thomas T., Thomas G., Mclendon C.et al. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;168-171.
20. Furchgott R.F. Role of endothelium in responses of vascular smooth muscle. Circ Res. 53:1983;557-573.
21. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation. 60:1979;473-480.
22. Havel R.J., Rapaport E. Management of primary hyperlipidaemia. New Engl J Med. 332:1995;1491-1498.